Polychlorinated biphenyl-xenobiotic nuclear receptor interactions regulate energy metabolism, behavior, and inflammation in non-alcoholic-steatohepatitis

Toxicological Sciences

Volumn 149, Issue 2, 2016, Pages 396-410

  Wahlang, Banrida ^a   Prough, Russell A ^a   Falkner, K Cameron ^a   Hardesty, Josiah E ^a   Song, Ming ^a   Clair, Heather B ^a   Clark, Barbara J ^a   States, J Christopher ^a   Arteel, Gavin E ^a   Cave, Matthew C ^a,b,c  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c JEWISH HOSPITAL   (United States)

Author keywords

Aroclor 1260; energy metabolism; nuclear receptors; PCBs; steatohepatitis

Indexed keywords

AROCLOR 1260; CARNITINE PALMITOYLTRANSFERASE I; CHOLESTEROL; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 2B; CYTOCHROME P450 2B10; CYTOCHROME P450 3A11; FATTY ACID BINDING PROTEIN; FATTY ACID SYNTHASE; GLUCOSE 6 PHOSPHATASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PREGNANE X RECEPTOR; STEAROYL COENZYME A; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CELL RECEPTOR; GLUCOSE; POLYCHLORINATED BIPHENYL; STEROID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; ENERGY METABOLISM; FOOD INTAKE; GENE EXPRESSION; GLUCOSE TOLERANCE; INFLAMMATION; INSULIN SENSITIVITY; LIPID METABOLISM; LUNG GAS EXCHANGE; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PERIODICITY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN INTERACTION; WILD TYPE; ANIMAL; ANIMAL BEHAVIOR; BODY COMPOSITION; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; BODY COMPOSITION; ENERGY METABOLISM; GLUCOSE; INFLAMMATION; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYCHLORINATED BIPHENYLS; PULMONARY GAS EXCHANGE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID;

EID: 84960105228     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfv250     Document Type: Article

References (43)

1. Bligh, E. G., and Dyer, W. J. (1959). A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917.
2. Cave, M., Appana, S., Patel, M., Falkner, K. C., McClain, C. J., and Brock, G. (2010). Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004. Environ. Health Perspect. 118, 1735-1742.
3. Dmitrienko, A., Molenberghs, G., Chuang-Stein, C., and Offen, W. (2005). Analysis of Clinical Trials Using SASVR: A practical Guide. SAS Institute Inc., Cary, NC.
4. Dong, B., Saha, P. K., Huang, W., Chen, W., Abu-Elheiga, L. A., Wakil, S. J., Stevens, R. D., Ilkayeva, O., Newgard, C. B., Chan, L., et al. (2009). Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc. Natl. Acad. Sci. U. S. A. 106, 18831-18836.
5. Fernandez, A., Matias, N., Fucho, R., Ribas, V., Von Montfort, C., Nuno, N., Baulies, A., Martinez, L., Tarrats, N., Mari, M., et al. (2013). ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading. J. Hepatol. 59, 805-813.
6. Gao, J., He, J., Zhai, Y., Wada, T., and Xie, W. (2009). The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J. Biol. Chem. 284, 25984-25992.
7. Gerbal-Chaloin, S., Iankova, I., Maurel, P., and Daujat-Chavanieu, M. (2013). Nuclear receptors in the cross-talk of drug metabolism and inflammation. Drug Metab. Rev. 45, 122-144.
8. Gray, S. L., Shaw, A. C., Gagne, A. X., and Chan, H. M. (2013). Chronic exposure to PCBs (Aroclor 1254) exacerbates obesityinduced insulin resistance and hyperinsulinemia in mice. J. Toxicol. Environ. Health A 76, 701-715.
9. Handschin, C., and Meyer, U. A. (2003). Induction of drug metabolism: The role of nuclear receptors. Pharmacol. Rev. 55, 649-673.
10. Hernandez, J. P., Mota, L. C., and Baldwin, W. S. (2009). Activation of CAR and PXR by dietary, environmental and occupational chemicals alters drug metabolism, intermediary metabolism, and cell proliferation. Curr. Pharmacogenomics Person. Med. 7, 81-105.
11. Hu, G., Xu, C., and Staudinger, J. L. (2010). Pregnane X receptor is SUMOylated to repress the inflammatory response. J. Pharmacol. Exp. Ther. 335, 342-350.
12. Jensen, T. K., Timmermann, A. G., Rossing, L. I., Ried-Larsen, M., Grontved, A., Andersen, L. B., Dalgaard, C., Hansen, O. H., Scheike, T., Nielsen, F., et al. (2014). Polychlorinated biphenyl exposure and glucose metabolism in 9-year-old Danish children. J. Clin. Endocrinol. Metab. 99, E2643-E26451.
13. Kliewer, S. A., Goodwin, B., and Willson, T. M. (2002). The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr. Rev. 23, 687-702.
14. Kodama, S., Koike, C., Negishi, M., and Yamamoto, Y. (2004). Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol. Cell Biol. 24, 7931-7940.
15. Kodama, S., Moore, R., Yamamoto, Y., and Negishi, M. (2007). Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene. Biochem. J. 407, 373-381.
16. Konno, Y., Negishi, M., and Kodama, S. (2008). The roles of nuclear receptors CAR and PXR in hepatic energy metabolism. Drug Metab. Pharmacokinet. 23, 8-13.
17. Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
18. Louet, J. F., Hayhurst, G., Gonzalez, F. J., Girard, J., and Decaux, J. F. (2002). The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4 alpha and cAMP-response element-binding protein (CREB). J. Biol. Chem. 277, 37991-8000.
19. Ma, Y., and Liu, D. (2012). Activation of pregnane X receptor by pregnenolone 16 alpha-carbonitrile prevents high-fat dietinduced obesity in AKR/J mice. PLoS One 7, e38734.
20. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995). The nuclear receptor superfamily: The second decade. Cell 83, 835-839.
21. Mayes, B. A., McConnell, E. E., Neal, B. H., Brunner, M. J., Hamilton, S. B., Sullivan, T. M., Peters, A. C., Ryan, M. J., Toft, J. D., Singer, A. W., et al. (1998). Comparative carcinogenicity in Sprague-Dawley rats of the polychlorinated biphenyl mixtures Aroclors 1016, 1242, 1254, and 1260. Toxicol. Sci. 41, 62-76.
22. Merrell, M. D., and Cherrington, N. J. (2011). Drug metabolism alterations in nonalcoholic fatty liver disease. Drug Metab. Rev. 43, 317-334.
23. Mooijaart, S. P., Brandt, B. W., Baldal, E. A., Pijpe, J., Kuningas, M., Beekman, M., Zwaan, B. J., Slagboom, P. E., Westendorp, R. G., and van Heemst, D. (2005). C. elegans DAF-12, Nuclear Hormone Receptors and human longevity and disease at old age. Ageing Res. Rev. 4, 351-371.
24. Moya, M., Gomez-Lechon, M. J., Castell, J. V., and Jover, R. (2010). Enhanced steatosis by nuclear receptor ligands: A study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile. Chem. Biol. Interact. 184, 376-387.
25. Nakamura, K., Moore, R., Negishi, M., and Sueyoshi, T. (2007). Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver. J. Biol. Chem. 282, 9768-9776.
26. Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015). Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial. Lancet 385, 956-965.
27. Novac, N., and Heinzel, T. (2004). Nuclear receptors: Overview and classification. Curr. Drug Targets Inflamm. Allergy 3, 335-346.
28. Perkins, J. T., Petriello, M. C., Newsome, B. J., and Hennig, B. (2015). Polychlorinated biphenyls and links to cardiovascular disease. Environ. Sci. Pollut. Res. Int. 23, 2160-2172.
29. Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010). Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362, 1675-1685.
30. Schecter, A., Colacino, J., Haffner, D., Patel, K., Opel, M., Papke, O., and Birnbaum, L. (2010). Perfluorinated compounds, polychlorinated biphenyls, and organochlorine pesticide contamination in composite food samples from Dallas, Texas, USA. Environ. Health Perspect. 118, 796-802.
31. Silverstone, A. E., Rosenbaum, P. F., Weinstock, R. S., Bartell, S. M., Foushee, H. R., Shelton, C., and Pavuk, M. (2012). Polychlorinated biphenyl (PCB) exposure and diabetes: Results from the Anniston Community Health Survey. Environ. Health Perspect. 120, 727-732.
32. Spruiell, K., Richardson, R. M., Cullen, J. M., Awumey, E. M., Gonzalez, F. J., and Gyamfi, M. A. (2014). Role of pregnane X receptor in obesity and glucose homeostasis in male mice. J. Biol. Chem. 289, 3244-3261.
33. Ueda, A., Hamadeh, H. K., Webb, H. K., Yamamoto, Y., Sueyoshi, T., Afshari, C. A., Lehmann, J. M., and Negishi, M. (2002). Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol. Pharmacol. 61, 1-6.
34. Wada, T., Gao, J., and Xie, W. (2009). PXR and CAR in energy metabolism. Trends Endocrinol. Metab. 20, 273-279.
35. Wahlang, B., Beier, J. I., Clair, H. B., Bellis-Jones, H. J., Falkner, K. C., McClain, C. J., and Cave, M. C. (2013). Toxicant-associated steatohepatitis. Toxicol. Pathol. 41, 343-360.
36. Wahlang, B., Falkner, K. C., Clair, H. B., Al-Eryani, L., Prough, R. A., States, J. C., Coslo, D. M., Omiecinski, C. J., and Cave, M. C. (2014a). Human receptor activation by aroclor 1260, a polychlorinated biphenyl mixture. Toxicol Sci. 140, 283-297.
37. Wahlang, B., Song, M., Beier, J. I., Cameron Falkner, K., Al-Eryani, L., Clair, H. B., Prough, R. A., Osborne, T. S., Malarkey, D. E., Christopher States, J., et al. (2014b). Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and nonalcoholic fatty liver disease. Toxicol. Appl. Pharmacol. 279, 380-390.
38. Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., and Moore, D. D. (2000). The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407, 920-923.
39. Weir, J. B. (1949). Newmethods for calculating metabolic rate with special reference to proteinmetabolism. J. Physiol. 109, 1-9.
40. Wolfrum, C., Asilmaz, E., Luca, E., Friedman, J. M., and Stoffel, M. (2004). Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432, 1027-1032.
41. Wolfrum, C., Besser, D., Luca, E., and Stoffel, M. (2003). Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc. Natl. Acad. Sci. U. S. A. 100, 11624-11629.
42. Zhai, Y., Wada, T., Zhang, B., Khadem, S., Ren, S., Kuruba, R., Li, S., and Xie, W. (2010). A functional cross-talk between liver X receptor-alpha and constitutive androstane receptor links lipogenesis and xenobiotic responses. Mol. Pharmacol. 78, 666-674.
43. Zhou, C., Tabb, M. M., Nelson, E. L., Grun, F., Verma, S., Sadatrafiei, A., Lin, M., Mallick, S., Forman, B. M., Thummel, K. E., et al. (2006). Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J. Clin. Invest. 116, 2280-2289.